What is the Courts and Tribunals Bill and what moved on 11 March?

MPs advanced the Courts and Tribunals Bill to committee for detailed scrutiny. Provisions include curbing some jury trials in defined areas to reduce the UK courts backlog. The next phase will set scope, safeguards, and review points through amendments, with timelines and oversight likely to dominate debate.

Why does Charlotte Nichols matter to investors?

Charlotte Nichols shared her experience of rape, focusing attention on victim confidence, timelines, and fairness. That public focus can shift trust in institutions and enforcement, which feeds into governance standards, risk premia, and disclosure practices across listed firms. Her intervention keeps scrutiny high through the committee stage.

How could jury trial reform change company timelines and costs?

If non-jury routes shorten listings, cases may resolve sooner. That can bring forward settlements, change legal fee run-rates, and alter insurance deductibles. Companies may need earlier cash outflows and updated risk disclosures. Faster clarity can also reduce uncertainty premia that weigh on valuations and borrowing costs.

What should UK investors watch next?

Monitor committee amendments on the scope of non-jury use, review clauses, and sunset dates. Track Ministry of Justice statistics on throughput and listing intervals. Recheck provisions, disclosure timetables, and cash buffers. If throughput improves, consider re-rating litigation-heavy names; if not, keep higher cash and limit exposure.

Law and Government

Charlotte Nichols Puts UK Jury Trial Bill in Investor Focus – March 11

ByDanny Kontos March 11, 2026March 11, 2026

Charlotte Nichols is driving investor focus after MPs moved the Courts and Tribunals Bill on 11 March. The bill would curb some jury trials to cut the UK courts backlog. Her testimony sharpened concern over trust in justice and case times. We outline what changed, why it matters for governance and cash flow, and how to track risk as the bill enters committee for amendments. For portfolios with legal exposures, even small shifts in listing or trial practice can change provisions, settlement timing, and liquidity planning.